Liver Cancer Tests Should Be Measured Against Ultrasound/AFP – NIH Panel
This article was originally published in The Gray Sheet
Executive Summary
Randomized controlled trials should be conducted to evaluate hepatocellular cancer (HCC) screening tests in high-risk patients, an 1NIH consensus conference draft statement on hepatitis C management concludes